Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00187460
Status:
COMPLETED
Last Update Posted:
2009-12-01
First Post:
2005-09-13
Brief Title:
Study of the Effectiveness of Report Cards on the Quality of Care for Heart Attack and Heart Failure Patients
Sponsor:
Sunnybrook Health Sciences Centre
Organization:
Sunnybrook Health Sciences Centre
Study Overview
Official Title:
Enhanced Feedback for Effective Cardiac Treatment EFFECT
Status:
COMPLETED
Status Verified Date:
2005-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EFFECT
Brief Summary:
Randomized cluster trial of cardiac report cards for AMI and CHF 103 acute care Ontario hospitals85 hospital corporations participating randomized to two groups Group A Early Feedback and Group B Delayed Feedback
Two phases of retrospective chart review of AMI and CHF separations to assess the impact of the public release of hospital specific performance on a set of Canadian quality indicators
Two phases of retrospective chart review of AMI and CHF separations to assess the impact of the public release of hospital specific performance on a set of Canadian quality indicators
Detailed Description:
Study Overview
The EFFECT Study is one of the largest and most comprehensive initiatives in the world to measure and improve the quality of cardiac care A randomized trial of cardiac care report cards the studys objective is to determine whether developing and publishing report cards based on clinical data collected from patient charts leads to greater use of evidence-based therapy at hospitals that receive them
The three-phase study focuses on acute myocardial infarction AMI and congestive heart failure CHF and involves 85 hospital corporations consisting of 103 acute care hospitals in Ontario As part of the study design the hospitals were randomized into two groups Group A-Early feedback hospitals 44 hospital corporations53 hospitals and Group B-Delayed feedback hospitals 41 hospital corporations50 hospitals
Phase I A retrospective chart review of hospitalizations from 199900 and 200001 was conducted in the participating Ontario hospital corporations Findings from Phase I were documented in two reports
Report 1 Report Cards on Group A-Early Feedback Hospitals released January 2004
Report 2 Report Cards on Group B-Delayed Feedback Hospitals to be released September 2005
In addition to demographic and treatment information study data also focus on two sets of quality indicators-one for AMI care and one for CHF care Canadian Cardiovascular Outcomes Research Team CCORT investigators in conjunction with the Canadian Cardiovascular Society CCS formed two expert panels to define Canadian AMI and CHF Quality Indicators The expert panels membership included clinical leaders in cardiology internal medicine family practice nursing pharmacy and epidemiology The indicators are posted on the CCORT web site wwwccortca and have been published in the Canadian Journal of Cardiology The studys Technical Advisory Committee reviewed all of the proposed AMI and CHF quality indicators and recommended a final list of indicators for inclusion in the EFFECT report cards
Phase II Report Cards for Group A-Early Feedback Hospitals and Group B-Delayed Feedback Hospitals based on a second phase of retrospective chart review of 200405 hospitalizations Release in 200607
Phase III Final Report-Impact Assessment A comparison of resultsimprovement from Phase I to Phase II Release in 200607
Sources of Funding The EFFECT study is being funded by the Canadian Institutes of Health Research CHIR Interdisciplinary Health Research Team IHRT Program and the Heart and Stroke Foundation of Canada with in kind support from the Institute for Clinical Evaluative Sciences
Principal Investigators The EFFECT study is being led by Dr Jack V Tu MD PhD Senior Scientist ICES Canada Research Chair Health Services Research
The EFFECT Study is one of the largest and most comprehensive initiatives in the world to measure and improve the quality of cardiac care A randomized trial of cardiac care report cards the studys objective is to determine whether developing and publishing report cards based on clinical data collected from patient charts leads to greater use of evidence-based therapy at hospitals that receive them
The three-phase study focuses on acute myocardial infarction AMI and congestive heart failure CHF and involves 85 hospital corporations consisting of 103 acute care hospitals in Ontario As part of the study design the hospitals were randomized into two groups Group A-Early feedback hospitals 44 hospital corporations53 hospitals and Group B-Delayed feedback hospitals 41 hospital corporations50 hospitals
Phase I A retrospective chart review of hospitalizations from 199900 and 200001 was conducted in the participating Ontario hospital corporations Findings from Phase I were documented in two reports
Report 1 Report Cards on Group A-Early Feedback Hospitals released January 2004
Report 2 Report Cards on Group B-Delayed Feedback Hospitals to be released September 2005
In addition to demographic and treatment information study data also focus on two sets of quality indicators-one for AMI care and one for CHF care Canadian Cardiovascular Outcomes Research Team CCORT investigators in conjunction with the Canadian Cardiovascular Society CCS formed two expert panels to define Canadian AMI and CHF Quality Indicators The expert panels membership included clinical leaders in cardiology internal medicine family practice nursing pharmacy and epidemiology The indicators are posted on the CCORT web site wwwccortca and have been published in the Canadian Journal of Cardiology The studys Technical Advisory Committee reviewed all of the proposed AMI and CHF quality indicators and recommended a final list of indicators for inclusion in the EFFECT report cards
Phase II Report Cards for Group A-Early Feedback Hospitals and Group B-Delayed Feedback Hospitals based on a second phase of retrospective chart review of 200405 hospitalizations Release in 200607
Phase III Final Report-Impact Assessment A comparison of resultsimprovement from Phase I to Phase II Release in 200607
Sources of Funding The EFFECT study is being funded by the Canadian Institutes of Health Research CHIR Interdisciplinary Health Research Team IHRT Program and the Heart and Stroke Foundation of Canada with in kind support from the Institute for Clinical Evaluative Sciences
Principal Investigators The EFFECT study is being led by Dr Jack V Tu MD PhD Senior Scientist ICES Canada Research Chair Health Services Research
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None